Am J Addict. 2010 Mar-Apr;19(2):187-9. "N-acetylcysteine (NAC) in young marijuana users: an open-label pilot study." Gray KM, Watson NL, Carpenter MJ, Larowe SD.
Prog Neuropsychopharmacol Biol Psychiatry. 2007 Mar 30;31(2):389-94. Epub 2006 Nov 17. "An open-label trial of N-acetylcysteine for the treatment of cocaine dependence: a pilot study."Mardikian PN, LaRowe SD, Hedden S, Kalivas PW, Malcolm RJ. Center for Drug and Alcohol Programs, Department of Psychiatry and Behavioral Sciences, Medical University of South Carolina, 67 President Street, Charleston, SC 29425, USA.
Innov Clin Neurosci. 2011 Jan;8(1):10-4. "Getting a Knack for NAC: N-Acetyl-Cysteine." Sansone RA, Sansone LA. Dr. R. Sansone is a professor in the Departments of Psychiatry and Internal Medicine at Wright State University School of Medicine in Dayton, Ohio.
Am Fam Physician. 2009 Aug 1;80(3):265-9., N-acetylcysteine: multiple clinical applications., Millea PJ. Mid-Atlantic Permanente Medical Group, P.C., Falls Church, VA 22046, USA.
J Psychiatry Neurosci. 2011 March; 36(2): 78-86. doi: 10.1503/jpn.100057 "N-acetylcysteine in psychiatry: current therapeutic evidence and potential mechanisms of action" Olivia Dean, BSc, PhD, Frank Giorlando, MBBS, BMedSc, and Michael Berk, MBBCh, MMed(Psych), PhD, Dean, Berk -- Mental Health Research Institute, Parkville; Dean, Giorlando, Berk -- Department of Clinical and Biomedical Sciences, Barwon Health, University of Melbourne, Geelong; Berk -- Youth Health Orygen Research Centre, Parkville, and the School of Medicine, Faculty of Health, Medicine, Nursing and Behavioural Sciences, Deakin University, Geelong, Victoria, Australia
Am J Psychiatry 2007;164:1115-1117. 10.1176/appi.ajp.164.7.1115, "Is Cocaine Desire Reduced by N-Acetylcysteine?" Steven D. LaRowe; Hugh Myrick; Sarra Hedden; Pascale Mardikian; Michael Saladin; Aimee McRae; Kathleen Brady; Peter W. Kalivas; Robert Malcolm
Respir J. 1997 Jul;10(7):1535-41 Attenuation of influenza-like symptomatology and improvement of cell-mediated immunity with long-term N-acetylcysteine treatment. De Flora S, Grassi C, Carati L.
Respir J. 1997 Jul;10(7):1535-41 Attenuation of influenza-like symptomatology and improvement of cell-mediated immunity with long-term N-acetylcysteine treatment. De Flora S, Grassi C, Carati L.
Toxicol Sci. 2011 Mar;120(1):87-97. Epub 2010 Dec 6. "The cytoprotective effect of N-acetyl-L-cysteine against ROS-induced cytotoxicity is independent of its ability to enhance glutathione synthesis." Zhang F, Lau SS, Monks TJ. Department of Pharmacology and Toxicology, College of Pharmacy, University of Arizona Health Science Center, Tucson, Arizona 85721, USA.
Biol Psychiatry. 2009 May 15;65(10):841-5. Epub 2008 Dec 21. "The role of cystine-glutamate exchange in nicotine dependence in rats and humans." Knackstedt LA, LaRowe S, Mardikian P, Malcolm R, Upadhyaya H, Hedden S, Markou A, Kalivas PW. Department of Neurosciences, Medical University of South Carolina, Charleston, South Carolina 29425, USA.
Biol Psychiatry. 2007 Sep 15;62(6):652-7. Epub 2007 Apr 18. "N-acetyl cysteine, a glutamate-modulating agent, in the treatment of pathological gambling: a pilot study." Grant JE, Kim SW, Odlaug BL. Department of Psychiatry, University of Minnesota School of Medicine, 2450 Riverside Avenue, Minneapolis, MN 55454, USA.
Archives of General Psychiatry, 2009;66(7):756-763. "N-Acetylcysteine, a Glutamate Modulator, in the Treatment of Trichotillomania: A Double-blind, Placebo-Controlled Study" Jon E. Grant, JD, MD, MPH; Brian L. Odlaug, BA; Suck Won Kim, MD, Department of Psychiatry, University of Minnesota School of Medicine, Minneapolis.
0 comments:
Post a Comment